Targeting AKT/PKB to improve treatment outcomes for solid tumors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting AKT/PKB to improve treatment outcomes for solid tumors

Published:2020-01 Issue: Volume:819-820 Page:111690
ISSN:0027-5107
Container-title:Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis
language:en
Short-container-title:Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis

Author:

Iida M.,Harari P.M.,Wheeler D.L.,Toulany M.

Funder

Wisconsin Head & Neck Cancer SPORE

German Research Council, Deutsche Forschungsgemeinschaft

Publisher

Elsevier BV

Subject

Health, Toxicology and Mutagenesis,Genetics,Molecular Biology

Reference170 articles.

1. Identification and characterization of pleckstrin-homology-domain-dependent and isoenzyme-specific Akt inhibitors;Barnett;Biochem. J.,2005

2. Full activation of PKB/Akt in response to insulin or ionizing radiation is mediated through ATM;Viniegra;J. Biol. Chem.,2005

3. Akt phosphorylation on Thr308 but not on Ser473 correlates with Akt protein kinase activity in human non-small cell lung cancer;Vincent;Br. J. Cancer,2011

4. Oncogenic kinase signalling;Blume-Jensen;Nature,2001

5. Targeting RTK signaling pathways in cancer;Regad;Cancers (Basel),2015

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural Perspectives in the Development of Novel EGFR Inhibitors for the Treatment of NSCLC;Mini-Reviews in Medicinal Chemistry;2024-10

2. HDAC6 inhibition disrupts HDAC6-P300 interaction reshaping the cancer chromatin landscape;Clinical Epigenetics;2024-08-18

3. Synergistic Antitumor Effects of 177Lu-Octreotide Combined with an ALK Inhibitor in a High-Risk Neuroblastoma Xenograft Model;Therapeutics;2024-08-07

4. The Induction of G2/M Phase Cell Cycle Arrest and Apoptosis by the Chalcone Derivative 1C in Sensitive and Resistant Ovarian Cancer Cells Is Associated with ROS Generation;International Journal of Molecular Sciences;2024-07-09

5. Research progress on anti-cancer mechanism of salidroside regulating miRNA-mRNA signaling axis;Oncologie;2024-07-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3